Friday, February 5, 2021
Equity Corporate Actions Alert #2021 - 15
Information Regarding the Business Combination of F S Development Corp. (FSDC) and Gemini Therapeutics, Inc.
Category:
Markets Impacted:Contact Information:
Resources: |
At a special meeting held on February 3, 2021, shareholders of F S Development Corp. (FSDC) approved the merger and business combination with Gemini Therapeutics, Inc. The business combination is anticipated to close today, Friday, February 5, 2021. As a result, the common stock of F S Development Corp. will be suspended from trading. The details are as follows:
Email Alert Subscriptions: Please follow Nasdaq on Facebook RSS and Twitter. Nasdaq (Nasdaq: NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 90 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to approximately 3,900 total listings with a market value of approximately $13 trillion. To learn more, visit: business.nasdaq.com. |
---|